Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...

Sen. Mark Kelly champions the PAIN Act to improve seniors' access to non-opioid pain treatments under Medicare.

Lexicon Pharmaceuticals is yet again defending a mixed set of data on its non-opioid pain prospect. | Lexicon Pharmaceuticals ...

Vivozon Pharmaceutical, a South Korean company specializing in the development and distribution of pharmaceutical drugs, is seeking to raise 250 million won ($17.2 million) as it prepares to launch ...

The company has chosen to move ahead to Phase III trials with its 10mg dose after it saw a 1.74-point reduction in pain score ...

U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...

A newly published study found that among drug users who experience chronic pain, daily cannabis use was linked to a higher ...

Treatment for chronic pain still relies heavily on opioids. While effective, they are highly addictive and potentially deadly ...

The hope is that a new generation of non-opioid analgesics will become available to treat both acute and chronic pain and have a reduced risk of addiction. In 2023, more than 100,000 lives were ...

A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.

A non-opioid drug for pain developed by UK biotech Levicept, with a new mechanism of action, has shown it can reduce pain associated with osteoarthritis in a phase 2 trial. Neurotrophin-3 (NT-3 ...